Delivery and formulation of engineered nucleic acids
US10898574B2 · kind B2 · utility
40Cited by
48References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2018 |
| Grant date | Jan 26, 2021 |
| Priority date | — |
| Expiry date | Mar 21, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/335
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.